Radiotherapy with or without immunotherapy in metastatic melanoma: efficacy and tolerability

Ellen Backlunda Department of Oncology, Karolinska University Hospital, Stockholm, Sweden;b Department of Oncology-Pathology, Karolinska Institutet, Stockholm, SwedenCorrespondence[email protected]
View further author information

Vitali Grozmanc Department of Diagnostic Radiology, Karolinska University Hospital, Sweden;d Department of Molecular Medicine and Surgery, Karolinska Institutet, StockholmView further author information

Suzanne Egyhazi Brageb Department of Oncology-Pathology, Karolinska Institutet, Stockholm, SwedenView further author information

Rolf Lewensohnb Department of Oncology-Pathology, Karolinska Institutet, Stockholm, SwedenView further author information

Karin Lindberga Department of Oncology, Karolinska University Hospital, Stockholm, Sweden;b Department of Oncology-Pathology, Karolinska Institutet, Stockholm, SwedenView further author information

Hildur Helgadottira Department of Oncology, Karolinska University Hospital, Stockholm, Sweden;b Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden

https://orcid.org/0000-0002-0735-4771 View further author information

Radiotherapy with or without immunotherapy in metastatic melanoma: efficacy and tolerability

Supplemental Material

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Radiotherapy with or without immunotherapy in metastatic melanoma: efficacy and tolerability

Supplemental Material

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date